Open-Label, DA Phase 1a/1b, Multicenter, ose-Escalation and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of AK127 in Combination with AK104 in Subjects with Advanced or Metastatic Solid Tumors

  • Frentzas, Sophia (Primary Chief Investigator (PCI))
  • Day, Daphne (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date2/12/21 → 1/12/26

Keywords

  • phase 1 study
  • treatment safety
  • treatment efficacy
  • solid tumour
  • pharmacokinetics